Dissecting the signaling pathways associated with the oncogenic activity of MLK3 P252H mutation

Sérgia Velho, Ana Pinto, Danilo Licastro

  • 1Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Dr, Roberto Frias, 4200-465 Porto,Portugal. rseruca@ipatimup.pt.

BMC Cancer
|March 18, 2014
PubMed
Abstract

Insights

Mutations in the MLK3 gene, particularly P252H, are linked to gastrointestinal cancers and tumor invasiveness. This study reveals MLK3 mutations deregulate key cancer pathways, including WNT signaling and planar cell polarity, offering insights into oncogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MLK3 gene mutations occur in approximately 20% of microsatellite unstable gastrointestinal cancers.
  • The P252H mutation in MLK3 exhibits significant transforming potential and promotes invasive tumor growth.
  • The precise molecular mechanisms of MLK3 P252H oncogenic activity remained unclear.

Purpose of the Study:

  • To identify signaling pathways dysregulated by the MLK3 P252H mutation.
  • To elucidate the molecular underpinnings of MLK3-driven oncogenesis in gastrointestinal cancers.

Main Methods:

  • Whole Genome arrays were performed on HEK293 cells stably transfected with wild-type MLK3, MLK3 P252H mutation, or an empty vector (Mock).
  • Analysis focused on identifying differential gene expression profiles associated with the MLK3 P252H mutation.

Main Results:

  • Mutant MLK3 deregulates critical colorectal cancer pathways: WNT, MAPK, NOTCH, TGF-beta, and p53.
  • Alterations in WNT signaling include downregulation of canonical pathway components (DVL2, LEF1, CCND1, c-Myc) and upregulation of the WNT inhibitor DKK.
  • Upregulation of FZD6 and FZD10 suggests activation of the non-canonical WNT planar cell polarity (PCP) pathway.

Conclusions:

  • Mutant MLK3 significantly alters cellular expression profiles, impacting key cancer-associated signaling pathways.
  • MLK3 P252H acts as a modulator of WNT signaling, potentially contributing to colorectal cancer development.
  • Activation of the PCP pathway by mutant MLK3 may underlie its role in promoting tumor invasiveness.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K